ARMONAIR Drug Patent Profile
✉ Email this page to a colleague
When do Armonair patents expire, and when can generic versions of Armonair launch?
Armonair is a drug marketed by Teva Pharm and is included in one NDA. There are five patents protecting this drug.
The generic ingredient in ARMONAIR is fluticasone propionate. There are twenty-nine drug master file entries for this compound. Seventy-five suppliers are listed for this compound. Additional details are available on the fluticasone propionate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Armonair
A generic version of ARMONAIR was approved as fluticasone propionate by ENCUBE on May 14th, 2004.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ARMONAIR?
- What are the global sales for ARMONAIR?
- What is Average Wholesale Price for ARMONAIR?
Summary for ARMONAIR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for ARMONAIR |
| DailyMed Link: | ARMONAIR at DailyMed |
US Patents and Regulatory Information for ARMONAIR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Pharm | ARMONAIR RESPICLICK | fluticasone propionate | POWDER;INHALATION | 208798-003 | Jan 27, 2017 | DISCN | Yes | No | 11,969,544*PED | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Teva Pharm | ARMONAIR DIGIHALER | fluticasone propionate | POWDER;INHALATION | 208798-008 | Apr 8, 2022 | DISCN | Yes | No | 11,344,685*PED | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Teva Pharm | ARMONAIR DIGIHALER | fluticasone propionate | POWDER;INHALATION | 208798-006 | Feb 20, 2020 | DISCN | Yes | No | 11,344,685*PED | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Teva Pharm | ARMONAIR RESPICLICK | fluticasone propionate | POWDER;INHALATION | 208798-001 | Jan 27, 2017 | DISCN | Yes | No | 11,969,544*PED | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Teva Pharm | ARMONAIR DIGIHALER | fluticasone propionate | POWDER;INHALATION | 208798-004 | Feb 20, 2020 | DISCN | Yes | No | 11,173,259*PED | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Teva Pharm | ARMONAIR DIGIHALER | fluticasone propionate | POWDER;INHALATION | 208798-008 | Apr 8, 2022 | DISCN | Yes | No | 10,918,816*PED | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
